As a center of excellence, St. Hope Foundation has medical experts fully competent in treating Hepatitis B & Hepatitis C. Under the direction of Dr. James Sims, MD, AAHIVS, Chief Medical Director, internal medicine and infectious disease physicians, our medical team stays abreast of the latest advancements in medical care.
With the new treatment developments for Hepatitis C and B, it has afforded patients more effective options to treat and clear or control these viruses.
Hepatitis C is a viral infection that causes liver inflammation, sometimes leading to serious liver damage. The hepatitis C virus (HCV) spreads through contaminated blood. Until recently, hepatitis C treatment required weekly injections that often had agonizing side effects. Today, chronic HCV is usually curable with oral medications taken every day for two to six months. Still, about half of people with HCV don’t know they’re infected, mainly because they have no symptoms, which can take decades to appear. The Centers for Disease Control and Prevention (CDC) recommends a one-time screening blood test for everyone at increased risk of the infection. The largest group at risk includes people born between 1945 and 1965 — a population five times more likely to be infected than those born in later years.
Hepatitis C is chronic for about 80% of sufferers. Patients who forego treatment are at increased risk for liver disease, liver cancer, and death.
Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV). For some people, hepatitis B infection becomes chronic, meaning it lasts more than six months. Having chronic hepatitis B increases your risk of developing liver failure, liver cancer, or cirrhosis — a condition that causes permanent scarring of the liver. Most people infected with hepatitis B as adults recover fully, even if their signs and symptoms are severe. Infants and children are more likely to develop a chronic hepatitis B infection. A vaccine can prevent it, but there’s no cure. If you’re infected, taking certain precautions can help prevent spreading HBV to others.
Persons with newly acquired HCV infection usually are asymptomatic or have mild symptoms that are unlikely to prompt a visit to a healthcare professional. When symptoms occur, they can include:
Approximately 20%–30% of those newly infected with HCV experience fatigue, abdominal pain, poor appetite, or jaundice.
In those persons who do develop symptoms, the average time period from exposure to symptom onset is 4–12 weeks (range: 2–24 weeks).
Most persons with chronic HCV infection are asymptomatic. However, many have chronic liver disease, which can range from mild to severe, including cirrhosis and liver cancer. Chronic liver disease in HCV-infected persons is usually insidious, progressing slowly without any signs or symptoms for several decades. In fact, HCV infection is often not recognized until asymptomatic persons are identified as HCV-positive when screened for blood donation or when elevated alanine aminotransferase (ALT, a liver enzyme) levels are detected during routine examinations.
HCV testing is recommended for anyone at increased risk for HCV infection, including:
Patients with chronic medical conditions have the opportunity to learn a great deal about their conditions from the internet. The St. Hope Foundation does not specifically endorse these websites. Rather, we believe the information provided will be useful, but please remember to consult your physician prior to making any significant change in your treatment regimen.
CDC – Hepatitis C – https://www.cdc.gov/hepatitis/index.htm
HCV Advocate – http://www.hcvadvocate.org/
Hepatitis C – Who Should Be Treated? – http://www.hivandhepatitis.com/hcv-treatment/hcv-treatment-guidelines/4801-new-aasldidsa-guidelines-who-should-be-treated-for-hepatitis-c-and-when
Privacy Policy | Blog | Locations | Contact